Interest Paid, Excluding Capitalized Interest, Operating Activities of CytoDyn Inc. from 31 May 2016 to 31 Aug 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
CytoDyn Inc. quarterly and annual Interest Paid, Excluding Capitalized Interest, Operating Activities in USD history and change rate from 31 May 2016 to 31 Aug 2025.
  • CytoDyn Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 31 Aug 2025 was $13,000, a 71% decline year-over-year.
  • CytoDyn Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $25,000, a 44% decline from 2023.
  • CytoDyn Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $45,000, a 137% increase from 2022.
  • CytoDyn Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $19,000, a 70% decline from 2021.
Source SEC data
View on sec.gov
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)

CytoDyn Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $13,000 -$32,000 -71% 01 Jun 2025 31 Aug 2025 10-Q 10 Oct 2025 2026 Q1
Q3 2024 $45,000 +$21,000 +88% 01 Jun 2024 31 Aug 2024 10-Q 10 Oct 2025 2026 Q1
Q3 2023 $24,000 01 Jun 2023 31 Aug 2023 10-Q 15 Oct 2024 2025 Q1
Q3 2021 $35,000 +$24,000 +218% 01 Jun 2021 31 Aug 2021 10-Q/A 13 Oct 2022 2023 Q1
Q3 2020 $11,000 +$1,000 +10% 01 Jun 2020 31 Aug 2020 10-Q 12 Oct 2021 2021 Q1
Q4 2019 $525,000 31 Aug 2019 30 Nov 2019 10-K 14 Aug 2020 2020 FY
Q3 2019 $10,000 +$10,000 01 Jun 2019 31 Aug 2019 10-Q 09 Oct 2020 2020 Q1
Q3 2018 $0 01 Jun 2018 31 Aug 2018 10-Q 08 Oct 2019 2020 Q1

CytoDyn Inc. Annual Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $25,000 -$20,000 -44% 01 Jun 2024 31 May 2025 10-K 25 Jul 2025 2025 FY
2023 $45,000 +$26,000 +137% 01 Jun 2023 31 May 2024 10-K 25 Jul 2025 2025 FY
2022 $19,000 -$44,000 -70% 01 Jun 2022 31 May 2023 10-K 15 Aug 2024 2024 FY
2021 $63,000 -$84,000 -57% 01 Jun 2021 31 May 2022 10-K 14 Sep 2023 2023 FY
2020 $147,000 -$96,000 -40% 01 Jun 2020 31 May 2021 10-K 15 Aug 2022 2022 FY
2019 $243,000 +$243,000 01 Jun 2019 31 May 2020 10-K 15 Aug 2022 2022 FY
2018 $0 -$9,157 -100% 01 Jun 2018 31 May 2019 10-K 14 Aug 2019 2019 FY
2017 $9,157 +$9,157 01 Jun 2017 31 May 2018 10-K 14 Aug 2020 2020 FY
2016 $0 -$26,890 -100% 01 Jun 2016 31 May 2017 10-K 14 Aug 2019 2019 FY
2015 $26,890 01 Jun 2015 31 May 2016 10-K 27 Jul 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.